Medical and Pharmaceutical bioAffinity jumps 45% from lung cancer phlegm test expansion It is the only commercially available test of its kind Rowan DunneSeptember 2, 2026
Medical and Pharmaceutical Young Muay Thai fighter’s lung cancer death raises screening eligibility concerns Many heavy smokers live into their senior years while others are taken far too young Rowan DunneAugust 23, 2026
Medical and Pharmaceutical AI-powered light scan could speed up targeted lung cancer treatments This technique, fluorescence lifetime imaging microscopy, could save patients and hospitals alot of money Rowan DunneJuly 13, 2026
Medical and Pharmaceutical PrognomiQ shares promising early results from novel lung cancer blood test Promising, but the findings are derived from a small study Rowan DunneMay 13, 2026
Medical and Pharmaceutical Guardant Health and Zydus to launch ‘Shield’ multi-cancer test in India The development complements a collaboration the companies initiated in 2023 Rowan DunneMay 6, 2026
Medical and Pharmaceutical Ohio’s ‘Breath of Hope’ Gala raises money for lung cancer research The event has generated over US$1.6 million since 2015 Rowan DunneApril 30, 2026
Health & Wellness American lung cancer survivor advocates for low-dose CT scans in new book She held a book signing for 'One Scan Saved My Life' this week Rowan DunneApril 2, 2026
Medical and Pharmaceutical bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction Shares rose by 73% during the session with no immediate catalyst Rowan DunneMarch 23, 2026
Medical and Pharmaceutical bioAffinity launches 2,000-patient study for noninvasive lung cancer test The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes Joseph MortonMarch 11, 2026
Medical and Pharmaceutical BioMark Diagnostics receives Innovation Award for lung cancer screening project It acknowledges the company’s development of an efficacious blood biopsy Rowan DunneDecember 3, 2025